Welcome to OCRA’s Advocate’s Corner, a new monthly series to keep you updated on how our Advocate Leaders and policy team are working on behalf of the ovarian and gynecologic cancer community.
OCRA’s Advocates are beginning 2024 with great momentum. Here’s a look at our most impactful achievements in 2023:
Co-founded a coalition to address the current chemotherapy drug shortage and prevent future shortages.
Nearly 300 advocates from 44 states met with 380+ Congressional offices to push for important initiatives, including expanded Medicare coverage of life-saving tools like genetic testing, at OCRA’s Spring and Fall Advocacy Days.
Secured 19 new co-sponsors on targeted legislation for federal education and awareness programs as a result of our Fall Advocacy Day.
Spearheaded Dear Colleague letters in both the U.S. House and Senate calling for an increase to $50 million for the Congressionally Directed Medical Research Program’s Ovarian Cancer Research Program. The bipartisan letters were signed by almost 100 legislators.
Initiated a research project to identify health disparities within gynecologic cancer outcomes, with an initial focus on racial and geographic disparities in care.
As the largest organization advocating on behalf of patients, survivors and families of those facing ovarian and related gynecologic cancers, OCRA is committed to effecting legislative change that can prevent more diagnoses, improve outcomes, and ease the financial burden of treatment and care.
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update: Government Shutdown Ends — What It Means for the Cancer Community As you are no doubt aware, after 43 days, the federal government shutdown officially ended. On November 12, 2025, President Donald J. Trump signed the temporary funding bill passed by Congress, reopening … Continued
New policy hub builds on record of helping to secure billions in federal funding and training thousands of advocates, with expanded priorities and an interactive policy map New York, NY – [November 20, 2025] — Ovarian Cancer Research Alliance (OCRA) today announced the launch of its Center for Public Policy, a dedicated hub that reflects expanded policy … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance Federal Update As of this writing, Congress has failed to come to an agreement on funding for the current fiscal year and the federal government is in a shutdown. We are closely monitoring the impact that the shutdown is having on the patient community and … Continued
